Blog

PNI’s Year-in-Review 2020 was, despite the pandemic, a strong year for clinical care delivered by PNI providers with multiple milestones being achieved.  We’ve entered 2021 with a deep commitment to treating our patients at our ten centers of excellence, doing groundbreaking research, providing innovative clinical...

The ability to maintain one’s brain health throughout one’s life should be of utmost importance in pursuing health and longevity. The brain is remarkably plastic (neuroplasticity) giving it the ability to change and improve throughout your lifetime. Neural connections in the brain can adjust and...

Technology apps give you power in cancer care In a terrible accident, astronaut Steve Austin was severely injured and rushed to a top-secret high-tech facility. In a government-sanctioned surgery, scientists and doctors worked around the clock using experimental technology to install a bionic arm, eye,...

One in ten Americans who are 65 and older suffer from Alzheimer’s dementia. It’s the 6th leading cause of death in the country, and it is a scourge worldwide. But little is known about what causes Alzheimer’s, and cures have been elusive. Dr. Verna Porter specializes in treating people with Alzheimer’s, and she remains optimistic.

Although our medical community continues to strain under the burden of COVID-19, there has been hope, determination and progress. Neurological diseases do not stop and neither have we at Pacific Neuroscience Institute.

In the Multiple Sclerosis Special Fall 2020 issue of Brain & Life, guest editor, Barbara Giesser, MD, FAAN, FANA, writes, “Living with multiple sclerosis requires patience and diligence, but the prognosis for leading a full life is better than ever.”

There’s a perception that because there isn’t a cure for PD, that means there’s no treatment, no way to improve symptoms, no way to improve quality of life. This is absolutely WRONG – there’s always more we can do!

Addiction and depression are two of the most widespread conditions in all of medicine. After decades of research, doctors are still looking for alternatives for when medication and cognitive training don’t work, which is all too often.

A new self-administered drug for the treatment of Multiple Sclerosis has been approved by the US Food and Drug Administration (FDA). In a clinical trial, it outperformed an existing oral drug, with respect to decreasing relapses and new areas of nerve damage seen on MRI....

As physicians, we understand the tremendous value of cognitive, physical, and social activity in optimizing and preserving our abilities as we age. At first glance, it is easy to see COVID as an obstacle. However, there are many ways we can emerge from this period sharper, stronger and more resilient.